Background-Human atrial fibrillation (AF) can terminate after ablating localized regions, which supports the existence of localized rotors (spiral waves) or focal drivers. However, it is unclear why ablation near a spiral wave tip would terminate AF and not anchor reentry. We addressed this question by analyzing competing mechanisms for AF termination in numeric simulations, referenced to clinical observations. Methods and Results-Spiral wave reentry was simulated in monodomain 2-dimensional myocyte sheets using clinically realistic rate-dependent values for repolarization and conduction. Heterogeneous models were created by introduction of parameterized variations in tissue excitability. Ablation lesions were applied as nonconducting circular regions. Models confirmed that localized ablation may anchor spiral wave reentry, producing organized tachycardias. Several mechanisms referenced to clinical observations explained termination of AF to sinus rhythm. First, lesions may create an excitable gap vulnerable to invasion by fibrillatory waves. Second, ablation of rotors in regions of low-excitability (from remodeling) produced re-entry in more excitable tissue allowing collision of wavefront and back. Conversely, ablation of rotors in high-excitability regions migrated spiral waves to less excitable tissue, where they detached to collide with nonconducting boundaries. Third, ablation may connect rotors to nonconducting anatomic orifices. Fourth, reentry through slow-conducting channels may terminate if ablation closes these channels. Conclusions-Limited ablation can terminate AF by several mechanisms. These data shed light on how clinical AF may be sustained in patients' atria, emphasizing heterogeneities in tissue excitability, slow-conducting channels, and obstacles that are increasingly detectable in patients and should be the focus of future translational studies. (Circ Arrhythm
A trial fibrillation (AF) is the commonest sustained arrhythmia, affecting 30 million patients worldwide.
1 AF increases morbidity and mortality yet therapy remains suboptimal, partly because of incomplete mechanistic understanding. Recent clinical studies show sources in the form of spiral wave reentry (rotors) or focal drivers sustaining AF 2, 3 and improved success with their ablation. However, in traditional basic science and simulation studies, ablation should not terminate such sources, instead even anchoring an AF rotor.
We studied mechanisms by which limited ablation may terminate AF, testing competing hypotheses in numeric models referenced to clinical observations. Our central hypothesis was that increasingly recognized functional and anatomic heterogeneities in human atria [3] [4] [5] [6] [7] [8] may enable the elimination of AF-sustaining regions by localized interventions.
In traditional hypotheses, AF results from self-sustaining, nonhierarchical disordered waves, yet several clinical studies show AF may terminate with localized ablation 2, 9 . Strategies insufficient to limit critical mass such as focal lesions, lines, incomplete PV isolation, or patchy ablation of complex electrograms [10] [11] [12] may be successful. New data from in vivo contact mapping, 2 the ECG-based inverse solution, 3 and recently optical mapping of human AF 13 support an alternative explanation-in which disordered activity is driven by localized rotors or focal sources. In the case of focal impulse and rotor mapping (FIRM), 2.1±1.1 cm 2 of tissue area is ablated per source, 14 which, given 2 to 4 sources per patient, represents a small fraction of the ≈100 to 130 cm 2 left atrial area in persistent patients with AF. 15 These data challenge the nonhierarchical model of AF in which successful therapy must limit critical mass. 16, 17 Conversely, it is undefined how localized ablation eliminates reentrant sources for AF 18 without anchoring them. Termination of microreentrant atrial tachycardia (AT) with localized ablation without connecting to nonconducting obstacles or limiting critical mass 19 -a common resultoffers a similar conundrum.
In this study, we numerically investigated the effects of ablation lesions on spiral wave reentry, incorporating increasingly appreciated nonuniformities in atrial physiology that may enable ablation to terminate AF, using clinical results to corroborate numeric findings.
Methods

Simulations
Simulations were performed in isotropic 2-dimensional (2D) sheets using the monodomain equation:
(1) Here, V is the membrane voltage, C m =1 μF/cm 2 represents the membrane capacitance, D the diffusion tensor with diagonal entries of D=0.001 cm 2 /ms, and I ion the membrane currents. Membrane currents were implemented by the Fenton-Karma (FK) model. 20, 21 Parameter values for the FK model were chosen from set 3, 21 and excitability was modified through the parameter τ d . As demonstrated, 21 this set and variations in τ d can capture different spiral wave dynamics, including nonmeandering and meandering spiral tips as well as spiral wave breakup. Notably, other parameter sets or detailed electrophysiological models give similar dynamics, and termination mechanisms discussed are not unique to a specific parameter set or model. Equation 1 was simulated on a square grid using a standard finite difference scheme with spatial discretization of 0.025 cm and time-step of 0.05 ms. These values of spatial and temporal discretization ensured conduction velocity (CV) and action potential durations (APDs) were <3% of their converged values with resulting activation waves qualitatively unchanged. 20 During 1000-ms cycle length pacing, CV and APD for the parameter set were 42.5 cm/s and 270 ms, respectively. These values can be adjusted arbitrarily by multiplying all time constants and the diffusion coefficient with a constant. Computational details are detailed in Table. Ablation lesions were modeled as circular regions of radius R abl with zero conductivity, rendering the tissue inexcitable. R abl was varied in steps of 0.05 cm (range, 0.2-1.0 cm). To account for zeroflux boundary conditions at the edge of the disk-like region, we use the phase-field method, 22 which is well suited to model appropriate boundary conditions on curved interfaces while using a finite difference grid. 23, 24 The edges of the computational domain are assumed to have zero-flux boundary conditions unless otherwise specified.
Cardiac tissue can exhibit significant nonuniformities as a result of local differences in APD restitution, conduction [5] [6] [7] [8] , centered in the computational domain. The value of the excitability parameter was varied in a linear and radial fashion from τ d1 to τ d2 :
where r is location in the computational domain relative to its center. Reentry arose from either cross-stimulation or using a broken wave as initial conditions. Several perturbations were then introduced as described in Results section of this article. Typical simulation times ranged from 1 to 7 min on a workstation equipped with a dual 2.4 GHz quad-core Intel Xeon processor. Spiral tip trajectories were computed using a standard tracking algorithm.
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Clinical Studies
An institutional review committee approved all clinical studies, and subjects gave informed consent. The approach to mapping human AF and ablating localized sources has been detailed by our group 2 and others. 3, [25] [26] [27] We studied patients referred for ablation of symptomatic paroxysmal or persistent AF for standard indications. 2 After discontinuation of antiarrhythmic medications, 2 AF was recorded from biatrial multipolar contact catheters. Recordings were analyzed using methods described 2 to interpret electrograms based on human repolarization 28 and conduction 5, 7 dynamics. Electric rotors were defined as phase singularities that radiate electric waves into surrounding tissue at high rate causing wavebreak into fibrillation, 29 whereas focal impulses showed centrifugal activation from an origin. AF sources identified using contact mapping process (wobble) in reproducible and limited areas 14 for long periods of time, 30 whereas drivers mapped by the inverse solution also occur in reproducible and limited regions for days. 3 Ablation of each AF source involved application of radiofrequency energy to the ≈2 to 3 cm 2 precession area. 14 This process (FIRM) was repeated for each source (2.1±1.1 per patient).
2 Subsequent clinical care included conventional ablation. 10 In this report, we focus only on the impact of limited FIRM-guided ablation to acutely terminate AF. We illustrate modeling-predicted mechanisms of AF termination with examples from our experience of FIRM-guided ablation.
Results
Computational simulations revealed several mechanisms by which limited ablation interfered with spiral wave reentry, converting AF to organized tachycardias, or terminating AF to sinus rhythm. These mechanisms were consistent with several observed clinical cases of rotor targeted (FIRM guided) ablation.
Conversion of AF to AT
Targeted ablation (a nonconducting obstacle) may pin a spiral wave to fixed reentry around the obstacle. Figure 1A shows a numeric example of a spiral wave with meander (green
WHAT IS KNOWN
• Spiral waves (rotors) and focal sources may drive atrial fibrillation (AF) as recently shown in humans. Limited ablation may disrupt anchor spiral waves, converting AF into atrial tachycardia (AT), but should not terminate AF to sinus rhythm without extensive, linear ablation.
• However, targeted ablation is well known to terminate clinical micro-reentrant AT to sinus rhythm, and has been shown to terminate AF rotors to sinus rhythm in recent clinical studies.
WHAT THE STUDY ADDS
• Using computational models incorporating recognized heterogeneities in repolarization or excitability, limited ablation was able to terminate spiral wave re-entry by creation of an excitable gap, dislodgement or closing of critical isthmuses.
• As predicted, targeted ablation can also anchor a spiral wave to atrial tachycardia and linear ablation from a spiral tip to anatomic or functional barriers can also terminate re-entry.
• These computational mechanisms were consistent with clinical cases employing focal impulse and rotor modulation (FIRM) guided ablation at sites of proven AF termination.
line, shown for ≈900 ms) causing AF in surrounding tissue. An ablation lesion (blue disk) alters tip trajectory (red line), and after ≈1200 ms, the spiral tip is stably anchored at the lesion. This spiral wave produces regular AT with cycle length 210 ms. As reported in other computational studies, 31 ,32 spiral wave anchoring requires a minimum lesion size, dependent on location. Figure 1B presents more complex activation with 3 coexisting meandering spiral waves, created by increasing the computational domain and introducing periodic boundary conditions in the horizontal direction (Table) . The rotors were initiated using conditions containing broken waves and coexisted for an extended duration (>4 s). An ablation lesion anchors one of the spirals and, after a period of ≈2000 ms, annihilation of other spirals ( Figure 1C ). Activation is now regular and consistent with AT of cycle length 230 ms.
Next, simulations revealed several mechanisms enabling limited ablation to terminate spiral wave reentry, consistent with conversion of AF to sinus rhythm.
Elimination of Reentry by Creation of an Excitable Gap
First, we studied the impact of ablation creating an excitable gap near the rotor core. Figure 2A shows a snapshot of simulations in which the excitability parameter τ d produced multiple spiral waves, τ d =0.34. Creating a lesion ( Figure 2B ) anchored 1 spiral wave leaving a small excitable gap ( Figure  2C ). Activation from surrounding fibrillatory waves invaded this excitable gap, with a stochastic likelihood of wave collision causing block and terminating reentry ( Figure 2D ; Movie I in the Data Supplement). We verified that other values of τ d and domain sizes display the same termination mechanism. For example, simulations using τ d =0.32 in a 5×5-cm domain and τ d =0.36 in a 7.5×7.5 cm result in spiral wave dislodgement by surrounding waves, followed by termination.
Elimination of Reentry Related to Gradients in Tissue Excitability
To address mechanisms based on spatial heterogeneities in tissue, we varied the FK model excitability parameter, τ d , in a radial fashion (Methods section of this study). Initially, we created a spiral wave stably attached to a nonconducting zone with a radius of 0.4 cm ( Figure 3 ) and investigated 2 scenarios: one in which excitability increased with distance from the nonconducting zone and another in which it decreased. An ablation lesion introduced over the initial nonconducting zone but of larger radius was able to unpin the anchored spiral in both scenarios. Figure 3A and 3B illustrates the first scenario, with excitability higher within the dashed circle than in surrounding tissue (τ d1 =0.3 to τ d2 =0.42, with corresponding CVs of 36.7 and 26.3 cm/s, respectively). Ablating the heterogeneous highexcitability domain results in a nonconducting zone (radius, 0.8 cm), detachment of the spiral wave, consequent migration and collision with anatomic obstacles (modeled as no-flux boundaries). This resulted in termination of the rotor and AF (Movie II in the Data Supplement). Varying ablation radius in steps of 0.05 cm revealed minimum ablation radius as 0.65 cm for the parameters in Figure 3A . We have verified other combinations of τ d1 , τ d2 , R 1 , and R 2 , which result in successful termination as well. For example, creating sufficiently large ablation lesions when changing either τ d1 (to 0.25) or R 1 (to 0.6 cm) only causes spiral wave termination. Clearly, minimum ablation size will depend on precise parameter values, but the qualitative termination behavior of Figure 3 is insensitive to parameter choices. Figure 3C to 3E illustrates the second scenario when ablation may terminate a spiral wave whose tip is located in a region of low excitability (R 1 =0.4 cm, τ d1 =0.35, and CV=33.0 cm/s) surrounded by higher excitability (τ d2 =0.25 and CV=42.6 cm/s). Initially, the activation front is anchored at a small, circular nonconducting obstacle. Creating an ablation lesion of larger radius results in the activation front propagating in tissue with higher excitability and correspondingly higher wave speed, allowing activation front and back to eventually meet, leading to block ( Figure 3E 
Terminating Reentry by Creating a Barrier to Nonconducting Obstacles
Targeted ablation could also terminate spiral waves if lesions connect to a large nonconducting obstacle (eg, an anatomic orifice or a large scar). Figure 4A shows a spiral wave with tip trajectory close to a nonconducting zone (the lower boundary of the simulation domain). Targeted ablation connecting the spiral wave core to this obstacle terminates reentry. This is shown in the snapshots displayed in Figure 4B and 4C, where we highlight wave block occurring in the gaps between lesions. The lesions prevent the wave from rotating ( Figure  4B ) and push it toward the nonconducting boundary where it extinguishes ( Figure 4C ). Note that ablation lesions need not overlap because isthmuses require a minimum size to support wave propagation, 33 ≈0.05 cm in our simulation.
Terminating Reentry by Ablation of an Isthmus for Reentry
In computational models, AF often exhibits paired spiral waves of opposite chirality, with 1 spiral extinguishing. We modeled a scenario whereby reentry is supported by a slow-conducting isthmus between nonconducting zones (hatched regions in Figure 5 ). The isthmus region has a linear gradient in diffusion constant ranging from D=0.0002 cm Figure 5D , green arrows; Movie IV in the Data Supplement). In this scenario, ablating the slow conduction zone blocks the reentry pathway, terminating reentry.
Clinical Cases Illustrating Various Mechanisms of AF Termination
Observations in several patients support the modeling-predicted mechanisms of AF termination. Figure 6 shows atrial propagation in a 67-year-old man with left atrial diameter 62 Figure 3 . Ablation of a spiral wave in tissue with heterogeneous excitability can result in wave detachment with subsequent termination. A and B, A region of high excitability (within dashed circle) surrounded by tissue with low excitability (tissue excitability falls linearly in the radial direction with R 1 =0.4 cm, R 2 =0.8 cm, τ d1 =0.3 to τ d2 =0.42, 5×5 cm domain). A, Snapshot of an activation front attached to a nonconducting disk of radius R=0.4 cm. B, Snapshot of activation after ablation of the region of higher excitability (R abl =0.8 cm). The wavefront finds itself in a region of low excitability, detaches from the obstacle, and migrates out of the computational domain, resulting in the termination of reentry. C-E, Ablation of a spiral wave in a region of low excitability. Tissue excitability within the dashed region varies radially and is lower closer to the obstacle (R 1 =0.4 cm, R 2 =2.5 cm, τ d1 =0.35 to τ d2 =0.25, 5×5 cm domain). C, Snapshot of a counter clockwise rotating activation front attached to a nonconducting zone of radius R=0.4 cm. D and E, Snapshots of the activation after ablation of a disk (radius R abl =0.8 cm). The wavefront encounters the wave back, resulting in block, indicated by the double bar. The wavefront subsequently detaches from the obstacle and migrates out of the computational domain, resulting in the termination of reentry (not shown). Scale bars, 1 cm. Figure 2 . An excitable gap created by ablation is invaded by fibrillatory waves to rapidly terminate spiral wave reentry. A, Multiple spiral waves exist before ablation. B, The abrupt creation of an ablation lesion (blue disk, nonconducting zone, R abl =0.6 cm) leads to an activation front that rotates around the zone in a counterclockwise fashion (indicated by red arrows) and an incoming wave (indicated by green arrows). C, The distance between the front and the back of the wave is large enough that an incoming wave can excite the tissue. This results in a wave collision and dislodgement of reentry (D). Domain size 5×5 cm, periodic boundary conditions in the horizontal direction. Scale bar, 1 cm. mm, persistent AF and no previous ablation, in whom brief ablation (cumulative duration 6 minutes for diameter ≈2 cm) at a counter clockwise left atrial rotor anchored spiral wave reentry to produce organized tachycardia at this region. The AT was then ablated to sinus rhythm. This example is consistent with the mechanism in Figure 1 . Figure 7 illustrates a 85-year-old man with a long history of AF but no previous ablation, in whom ablation at the first catheter position for <1 minute (<1-cm diameter) at the rotor core destabilized the previously stable rotor, terminating AF to sinus rhythm. This is consistent with the mechanism in Figure 3 , whereby the destabilized spiral wave tip may collide with the mitral annulus, left inferior pulmonary vein, or other structural boundary. Figure 8 shows cases of AF rotors near nonconducting boundaries. In Figure 8A , rotor ablation near the left superior pulmonary vein, during the first ablation of a patient with persistent AF, enabled AF termination after a cumulative of 2.5-minute energy delivery (≈1.3-cm diameter). In Figure 8B , in a patient with AF despite previous left atrial ablation (none in right atrium), ablation commenced at a rotor near the inferior vena cava. The first lesions delivered terminated AF to sinus rhythm after a total cumulative ablation time of 48 seconds (<1-cm diameter). These data are consistent with ablation connecting rotor cores to these nonconducting boundaries as illustrated in Figure 4 .
Finally, Figure I in the Data Supplement illustrates a case of paired rotors of opposite chirality in the right atrium in a 63-year-old man with persistent AF, left atrial diameter of 54 mm, and a dual-chamber pacemaker. We performed ablation at the medial rotor core only, as the lateral core lay at a pacemaker lead site.
Discussion
This work provides a novel theoretical foundation for AF, illustrating for the first time how limited ablation targeted to the site(s) of localized sources can terminate AF to sinus rhythm or organized AT. Although the clinical literature is replete with cases where limited ablation terminates AF, there has previously been no theoretical foundation explaining this phenomenon-using either nonhierarchical (ie, multiwavelet reentry) or hierarchical (ie, source) models of AF. The present study illustrates how increasingly recognized structural heterogeneities and functional nonuniformities in remodeled human atria may enable ablation to terminate AF, by nonuniform excitability, conduction, repolarization, and nonconducting obstacles. Clinically, these data may help to guide improved ablation strategies and, mechanistically, suggest specific approaches to modify AF substrates by ionic, antifibrotic, or regenerative therapies.
Disorganized or Localized Mechanisms Sustaining AF: A Fundamental Dilemma
Whether AF is maintained by nonhierarchical self-sustaining disorganization or is hierarchical such that localized regions 29 drive disorganization remains a central mechanistic debate. Answers to this question will affect decision making in AF therapy.
Disorganized sustaining mechanisms are supported by surgical studies demonstrating reentry without hierarchy using recording plaques. 34 However, these studies have limitations as clinical AF signals may reflect nonlocal activation, 35 complex signals are often ignored 34 and plaques only simultaneously map small regions (<10%-20% of both atria). This mechanism also cannot reconcile how AF is modulated by limited ablation, 9,25 why outcomes are worse when performing more ablation 12 (ie, undergoing greater mass reduction), and data directly challenging the critical mass concept. 17 Localized sources for fibrillation were demonstrated directly by the pioneering work of Pandit and Jalife 29 in the early 1990s and by recent optical mapping studies in human AF. 13 Sources readily explain modulation of AF by ablation, 2, 9 insufficient to limit critical mass, 10,12 AF termination by localized intervention, 36 and increasing data showing stability of propagation. A hierarchical model also explains success during extensive ablation if it coincidentally modifies sources. 37 One major question for the source hypothesis is how localized ablation at rotors can abolish AF. 18 The present study provides the first potential answers to that question. 
Reconciling Our Studies With Previous Work
First, the present study confirms previous computational 31, 32, 38, 39 and in vitro [40] [41] [42] studies where limited ablation converted an AF rotor to anatomic reentry. This is consistent with clinical cases ( Figure 6 ) using FIRM 2 or an ECG-based inverse solution, 3 supporting the localized source hypothesis. Studies are required to exclude ablation modulating high densities of multiple wavelets 18 although this would not explain why the unablated lower density wavelets do not perpetuate AF.
Second, this study provides the first set of mechanisms to explain how limited ablation terminates AF directly to sinus rhythm. Most numeric simulations studied anchoring of spiral waves to obstacles in uniform tissue, 31, 32, 38, 39, 43 revealing how both low and high excitability limit the minimum obstacle size around which reentry is stable. In tissue with uniformly low excitability, spiral tips cannot follow trajectories with high curvature. 44 Thus, stable attachment to a circular obstacle requires a minimum radius-if smaller, spiral waves will detach. In tissue with uniformly high excitability, the CV determines the minimum size of an anchoring obstacle. The CV is large (small) for high (low) excitability and, accordingly, highly excitable tissue can only support activation if the path around the obstacle has a minimum size-if smaller, activating head meets tail, detaching wavefronts. Thus, in uniform tissue, it is unlikely that limited ablation can dislodge an anchored spiral wave.
However, our study shows that incorporating well-recognized nonuniformities in atrial tissue reveals several mechanisms whereby limited targeted ablation can terminate AF rotors. Nonuniformities in atrial tissue are ubiquitous and possibly reflect regional variations in APD restitution, conduction, [5] [6] [7] [8] fibrosis, 4 or fiber architecture. 13 In the scenarios studied (Figure 3) , the initial condition consists of an activation front rotating around a small obstacle. The tissue properties close to this obstacle were chosen to differ from those further away. Note that this initial condition is stable because of this spatial heterogeneity: choosing uniform excitability equal to the excitability far from the obstacle would result in detachment in both cases. In the first scenario ( Figure 3A and 3B) , stable reentry around an obstacle in tissue with an excitability equal to that of the tissue further from the initial obstacle (τ d2 =0.42) requires a minimum obstacle radius of R=1.9 cm, much larger than a single ablation lesion (typical size 0.5-0.7 cm). Tissue with excitability corresponding to the parameter value at the periphery of Figure 3C and 3E (τ d2 =0.25) requires a minimum radius of R=1.2 cm, again larger than a lesion. This may explain how hyperkalemia terminates fibrillatory rotors.
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Validating Results From This Modeling Study With Clinical Observations
Ablation may lengthen wavepath around lesions, analogous to microreentrant AT. 46 A rapid microreentrant source driving AF with fibrillatory conduction may terminate if the excitable gap is invaded by fibrillatory waves. The effects of pacing on spiral tips have been studied before, 47 and we recently demonstrated in a case study of AF propagation using patient-specific geometries that fibrillatory waves can invade an excitable gap. 48 This model agrees with clinical observation, where even if AF is inducible, it may be shorter lived, with recurrence relating to ATs depending on the extent of ablated tissue. 3, 4, 14 Studies are needed to further define our description of conduction properties at sites of rotors and surrounding tissue 7 to identify patients in which gradients of excitability may operate.
The proposed mechanism of joining the rotor site to a nonconducting obstacle or eliminating a nonconducting channel both require direct clinical validation. However, Figure 8 illustrates rotors whose location would easily enable targeted ablation to connect to nonconducting boundaries including functional boundaries. Figure 1 in the Data Supplement shows figure-of-eight activation through slow-conducting channels, which may occur in relation to fibrosis or other forms of atrial remodeling, awaiting clinical mapping validation.
Limitations
There are several limitations of this study. First, it was performed in computational grids not accounting for geometric curvature, which may provide additional mechanisms for ablation to terminate AF. 29 Second, we used the FK model for computational efficiency, so our study was not designed to explore effects of derangements in specific ion channels or drugs on AF. Third, simulations were performed in isotropic domains, whereas fiber anisotropy can affect spiral tip dynamics. 29, 48 Fourth, ablation lesions were modeled as discrete obstacles to activation and conduction, while in practice the necrotic core of an ablation lesion is surrounded by a penumbra of inflammation that may shorten APD and alter wave dynamics. Additional studies should attempt to quantify such inflammation so that it may be incorporated. Fifth, simulations were performed in 2D sheets that did not include transmural components. Indeed, epicardial and endocardial differences in cellular and fiber properties were recently shown in optical mapping of human AF. 13 The study found stable rotors (≈1 cm 2 precession areas on the endocardium), terminated by localized ablation, but less stability on the epicardium, where they appeared as focal breakthroughs. It remains to be seen whether this transmural difference is consistent. We did not model the impact of ablation on potential focal sources for AF because this is mechanistically straightforward. Clinically, we were unable to directly register clinical cases with computational models. While rotors have been questioned, many studies either had signal processing issues such cycle lengths of 250-500 ms in patients ostensibly with AF or use of bipolar analyses on unipolar signals 49 or mapped small atrial areas.
34
Although FIRM-based mapping is sufficient to map human AF at the resolution required for ablation, 50 it is insufficient to map the dynamics of the rotor core during ablation. In the present study, clinical data illustrate model predictions and are not used to present a definitive mechanistic proof or a relationship to the long-term results of rotor ablation as shown by others 27 and for which randomized trials are ongoing.
Conclusions
This study proposes novel mechanisms by which limited ablation can terminate human AF. These data illustrate for the first time how targeted ablation may interact dynamically with the anatomic locations of rotors and with tissue characteristics of nonuniform excitability, slow conduction, and nonconducting boundaries. Future translational studies should focus on mapping and quantifying these tissue heterogeneities in remodeled atria in individual patients to improve therapy.
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